Rebuttal Letter to the Editor: Defending Evidence-Based Practices in Interventional Pain Medicine [Letter]. [PDF]
Kalia H, Suvar T, Chung M, Gulati A.
europepmc +1 more source
Chimeric Antigen Receptor T‐Cell Therapy and Autoimmune Diseases in the Nervous System
ABSTRACT Introduction Chimeric antigen receptor T‐cell (CAR‐T) therapy, a revolutionary immunotherapy originally developed for hematologic malignancies, has recently gained attention for its potential in treating autoimmune diseases. Increasing evidence suggests that CAR‐T cells can precisely target pathogenic immune populations, offering durable ...
Shun‐yu Yao +11 more
wiley +1 more source
A Comparative Study of Premixed Versus Succedent Administration of Dexmedetomidine and Bupivacaine in the Subarachnoid Block for Infraumbilical Surgeries. [PDF]
Bodra LS +5 more
europepmc +1 more source
New insights into applications of base editor in hereditary disorders
Abstract Hereditary disorders are a group of diseases caused by genetic mutations or chromosomal variations. Although the incidence of each genetic disorder is relatively low, patients affected by the disease generally experience a range of severe symptoms, including blindness, disability, and even premature death. In addition, the available treatments
Maoping Cai +8 more
wiley +1 more source
PD-L1 expression in cerebrospinal fluid for leptomeningeal metastasis from solid tumors: preliminary assessment of clinical implications. [PDF]
Pan Z +10 more
europepmc +1 more source
The Effect of Intrathecal Dexmedetomidine as an Adjuvant to Spinal Anesthesia: Double Blind Study
Shah Bipin K. +3 more
openalex +1 more source
ABSTRACT Neural stem cell (NSC)‐based therapies offer a promising strategy to promote brain repair by delivering neurotrophic factors, supporting cell replacement, and stimulating endogenous neurogenesis following injury. While numerous studies have highlighted the protective and regenerative potential of NSCs and their extracellular vesicles (EVs ...
Patrick Pirrotte +19 more
wiley +1 more source
Targeting the hypothalamic a11 nucleus to treat parkinsonian-like nociceptive impairments. [PDF]
Charles KA +5 more
europepmc +1 more source

